Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Schaison
G
G
Saint-Louis Hospital, Paris.
Sommelet
D
D
Bancillon
A
A
Perel
Y
Y
Leblanc
T
T
Bergeron
C
C
Lejars
O
O
Baruchel
A
A
Lepage
E
E
Leverger
G
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D011241:Prednisone / Q000008:administration & dosage; D012008:Recurrence; D012074:Remission Induction; D012307:Risk Factors; D014750:Vincristine / Q000008:administration & dosage; D014751:Vindesine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D001215:Asparaginase; D014751:Vindesine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin